January 09, 2026 a 03:43 pm
BIIB: Fundamental Ratio Analysis - Biogen Inc.
Biogen Inc. operates in the healthcare sector, focusing on discovering and delivering treatments for neurological and neurodegenerative diseases. The stock performance reflects the company’s strong market position in the MS treatment segment and its ongoing innovation in Alzheimer's therapies. Investors should consider the company's solid financials alongside potential risks from competitive pressures and regulatory challenges.
Fundamental Rating
The fundamental rating for Biogen Inc. demonstrates a strong performance with an overall score of 4. Key drivers include a robust DCF score and a healthy return on assets.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 3 | |
| Return on Assets | 4 | |
| Debt to Equity | 2 | |
| Price to Earnings | 3 | |
| Price to Book | 4 |
Historical Rating
Reviewing the historical scores provides insight into the company's performance consistency and trends over time.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-01-08 | 4 | 5 | 3 | 4 | 2 | 3 | 4 |
| Previous | 0 | 5 | 3 | 4 | 2 | 3 | 4 |
Analysts Price Targets
Analysts set a consensus price target of $181, with projections ranging from a high of $250 to a low of $143.
| High | Low | Median | Consensus |
|---|---|---|---|
| $250 | $143 | $171 | $181 |
Analysts Sentiment
The analyst sentiment indicates a buy recommendation with a majority of 25 buy ratings against one sell rating.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 25 | |
| Hold | 21 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Biogen Inc. presents a balanced investment opportunity with strong performance in its current product offerings and promising advancements in neurological treatments. While the stock benefits from solid fundamentals and positive analyst sentiment, investors need to remain cognizant of potential market volatility and external regulatory developments. Long-term growth appears reasonable assuming continuity in pipeline developments and market adoption.